Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,855 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study" [Endocrine Practice 30 (2024) 424-430].
Lin YH, Lin CH, Lin YC, Huang YY, Tai AS, Fu SC, Lin SH. Lin YH, et al. Among authors: lin ch, lin sh, lin yc. Endocr Pract. 2024 Sep;30(9):898. doi: 10.1016/j.eprac.2024.06.012. Epub 2024 Jul 17. Endocr Pract. 2024. PMID: 39023469 Free article. No abstract available.
Corrigendum to "Risk factors of first and recurrent genitourinary tract infection in patients with type 2 diabetes treated with SGLT2 inhibitors: a retrospective cohort study" [Diabetes Res. Clin. Pract. 186 (2022) 109816].
Lin YH, Lin CH, Huang YY, Tai AS, Fu SC, Chen ST, Lin SH. Lin YH, et al. Among authors: lin ch, lin sh. Diabetes Res Clin Pract. 2024 Dec;218:111925. doi: 10.1016/j.diabres.2024.111925. Epub 2024 Nov 24. Diabetes Res Clin Pract. 2024. PMID: 39581834 No abstract available.
Corrigendum to "Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study" [Endocrine Practice 30 (2024) 424-430].
Lin YH, Lin CH, Lin YC, Huang YY, Tai AS, Fu SC, Lin SH. Lin YH, et al. Among authors: lin ch, lin sh, lin yc. Endocr Pract. 2025 Apr;31(4):556. doi: 10.1016/j.eprac.2025.01.006. Epub 2025 Feb 13. Endocr Pract. 2025. PMID: 39945693 Free article. No abstract available.
2,855 results